References
- 1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of COPD. 2021 [accessed 2022 May 2]. Available from: http://www.goldcopd.org/
- 2. Walter RE, Wilk JB, Larson MG, et al. Systemic inflammation and COPD: the Framingham Heart Study. Chest 2008;133(1):19-25.
- 3. Soler-Cataluña JJ, Martínez-Garcta MA, Román Sánchez P, et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005;60(11):925-31.
- 4. Hilde JM, Hisdal J, Skjørten I, et al. Left ventricular dysfunction in COPD without pulmonary hypertension. PLoS ONE 2020;15(7):e0235075.
- 5. Pelá G, Li Calzi M, Pinelli S, et al. Left ventricular structure and remodeling in patients with COPD. Int J Chron Obstruct Pulmon Dis 2016;11(1):1015-22.
- 6. Render, ML, Weinstein, AS, Blaustein, AS. Left ventricular dysfunction in deteriorating patients with chronic obstructive pulmonary disease. Chest 1995;107:162-8.
- 7. Vizza CD, Lynch JP, Ochoa LL, et al. Right and left ventricular dysfunction in patients with severe pulmonary disease. Chest 1998;113;576-83.
- 8. Jardin F, Gueret P, Prost JF, et al. Two-dimensional echocardiographic assessment of left ventricular function in chronic obstructive pulmonary disease. Am Rev Respir Dis 1984;129:135-42.
- 9. Louridas G, Patakas D, Stavropoulos C. Left ventricular function in patients with chronic obstructive pulmonary disease. Cardiology 1981;67:73-80.
- 10. Saha B Kr, Sarkar D, Sarkar L, Bandyopadhyay R. Left ventricular dysfunction in chronic obstructive pulmonary disease. Int J Med Res Rev 2018; 6(07):385-90.
- 11. Simpson JA, Brunt KR, Collier CP, Iscoe S. Hyperinflation-induced cardiorespiratory failure in rats. J Appl Physiol. 2009;107(1):275-82.